Article

Metabolic Risk Factors in NonCVD Individuals and Their Trajectory Toward Cardiovascular Incidence

2025-07-02

Abstract excerpt

<title>Abstract</title> <p>Background In 2019, cardiovascular disease (CVD) was the primary cause of death worldwide, responsible for approximately 18.6 million fatalities, with its prevalence and incidence continuing to rise. In Iran, CVD accounts for 46.04% of all deaths, with demographic aging and sedentary lifestyles exacerbating the burden. This study evaluated the impact of metabolic risk factors and their...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 17908d7f-acdf-5060-98c1-98ad645a0826
DOI: 10.21203/rs.3.rs-6690336/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metabolic Risk Factors in NonCVD Individuals and Their Trajectory Toward Cardiovascular IncidenceDOI 10.21203/rs.3.rs-6690336/v1Read

Temporal Patterns of Cardiometabolic Risk Factors Preceding Incident Cardiovascular Disease: Evidence from the TLGSSemantic proximity Read

Cardiovascular risk factors in Iranian individuals with diabetes from 2007 to 2021: findings from STEPs surveysSemantic proximity Read

Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index and its derivatives in the prediction of 10-year cardiovascular mortality: insights from MASHAD cohort studySemantic proximity Read

Title: Cohort profile update: Tehran Cardiometabolic Genetic Study, a path toward precision medicineSemantic proximity Read

Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study.Semantic proximity Read

Association of obesity phenotypes with risk of cardiovascular disease mortality: a prospective cohort study.Semantic proximity Read

Association of metabolism score for visceral fat with new-onset cardiovascular disease in patients with metabolic syndrome: two large prospective cohorts in Europe and AsiaSemantic proximity Read

Trends in Prevalence, Risk-Factors Controls and Medications in ASCVD Among US Adults, 1999-2018Semantic proximity Read

Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study.Semantic proximity Read

Prevalence and correlates of metabolic syndrome and its components in nearly 10 million participants of northwestern China: a cross-sectional studySemantic proximity Read

Cumulative cholesterol–HDL–glucose–waist-to-height ratio and risk of cardiovascular disease: a nationwide prospective cohort studySemantic proximity Read

Transitions in Metabolic Health and Onset Age of Cardiovascular Diseases.Semantic proximity Read